Dyskinesias in Parkinsonian Syndromes

S. Zauber, Christopher G. Goetz

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Dyskinesia is an involuntary hyperkinetic movement disorder that may occur as a feature of parkinsonism or as an effect of drug treatment for the disease. In Parkinson's disease (PD) dyskinesia is common and may be disabling. The phenomenology of dyskinesia in PD varies primarily due to the level of brain dopamine from dopaminergic drugs in the context of dopaminergic cell degeneration. While changes in the dopaminergic system are essential for the development of dyskinesia, multiple other brain receptor systems are implicated in the pathophysiology. Currently only one drug, amantadine, reduces dyskinesia severity without worsening parkinsonism. Other treatment options consist of changes in dose and timing of dopaminergic drugs, as well as deep brain stimulation surgery.

Original languageEnglish
Title of host publicationHyperkinetic Movement Disorders: Differential Diagnosis and Treatment
PublisherWiley-Blackwell
Pages297-310
Number of pages14
ISBN (Print)1444333526, 9781444333527
DOIs
StatePublished - Feb 24 2012

Fingerprint

Dyskinesias
Parkinsonian Disorders
Dopamine Agents
Parkinson Disease
Hyperkinesis
Amantadine
Deep Brain Stimulation
Movement Disorders
Brain
Pharmaceutical Preparations
Therapeutics

Keywords

  • Corticobasal degeneration
  • Deep brain stimulation
  • Diphasic dyskinesia
  • Levodopa-induced-dyskinesia
  • Multiple system atrophy
  • Parkinson's disease
  • Pathophysiology
  • Progressive supranuclear palsy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Zauber, S., & Goetz, C. G. (2012). Dyskinesias in Parkinsonian Syndromes. In Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment (pp. 297-310). Wiley-Blackwell. https://doi.org/10.1002/9781444346183.ch19

Dyskinesias in Parkinsonian Syndromes. / Zauber, S.; Goetz, Christopher G.

Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment. Wiley-Blackwell, 2012. p. 297-310.

Research output: Chapter in Book/Report/Conference proceedingChapter

Zauber, S & Goetz, CG 2012, Dyskinesias in Parkinsonian Syndromes. in Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment. Wiley-Blackwell, pp. 297-310. https://doi.org/10.1002/9781444346183.ch19
Zauber S, Goetz CG. Dyskinesias in Parkinsonian Syndromes. In Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment. Wiley-Blackwell. 2012. p. 297-310 https://doi.org/10.1002/9781444346183.ch19
Zauber, S. ; Goetz, Christopher G. / Dyskinesias in Parkinsonian Syndromes. Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment. Wiley-Blackwell, 2012. pp. 297-310
@inbook{3fd5cb76a2a1426f806649c272950daf,
title = "Dyskinesias in Parkinsonian Syndromes",
abstract = "Dyskinesia is an involuntary hyperkinetic movement disorder that may occur as a feature of parkinsonism or as an effect of drug treatment for the disease. In Parkinson's disease (PD) dyskinesia is common and may be disabling. The phenomenology of dyskinesia in PD varies primarily due to the level of brain dopamine from dopaminergic drugs in the context of dopaminergic cell degeneration. While changes in the dopaminergic system are essential for the development of dyskinesia, multiple other brain receptor systems are implicated in the pathophysiology. Currently only one drug, amantadine, reduces dyskinesia severity without worsening parkinsonism. Other treatment options consist of changes in dose and timing of dopaminergic drugs, as well as deep brain stimulation surgery.",
keywords = "Corticobasal degeneration, Deep brain stimulation, Diphasic dyskinesia, Levodopa-induced-dyskinesia, Multiple system atrophy, Parkinson's disease, Pathophysiology, Progressive supranuclear palsy",
author = "S. Zauber and Goetz, {Christopher G.}",
year = "2012",
month = "2",
day = "24",
doi = "10.1002/9781444346183.ch19",
language = "English",
isbn = "1444333526",
pages = "297--310",
booktitle = "Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Dyskinesias in Parkinsonian Syndromes

AU - Zauber, S.

AU - Goetz, Christopher G.

PY - 2012/2/24

Y1 - 2012/2/24

N2 - Dyskinesia is an involuntary hyperkinetic movement disorder that may occur as a feature of parkinsonism or as an effect of drug treatment for the disease. In Parkinson's disease (PD) dyskinesia is common and may be disabling. The phenomenology of dyskinesia in PD varies primarily due to the level of brain dopamine from dopaminergic drugs in the context of dopaminergic cell degeneration. While changes in the dopaminergic system are essential for the development of dyskinesia, multiple other brain receptor systems are implicated in the pathophysiology. Currently only one drug, amantadine, reduces dyskinesia severity without worsening parkinsonism. Other treatment options consist of changes in dose and timing of dopaminergic drugs, as well as deep brain stimulation surgery.

AB - Dyskinesia is an involuntary hyperkinetic movement disorder that may occur as a feature of parkinsonism or as an effect of drug treatment for the disease. In Parkinson's disease (PD) dyskinesia is common and may be disabling. The phenomenology of dyskinesia in PD varies primarily due to the level of brain dopamine from dopaminergic drugs in the context of dopaminergic cell degeneration. While changes in the dopaminergic system are essential for the development of dyskinesia, multiple other brain receptor systems are implicated in the pathophysiology. Currently only one drug, amantadine, reduces dyskinesia severity without worsening parkinsonism. Other treatment options consist of changes in dose and timing of dopaminergic drugs, as well as deep brain stimulation surgery.

KW - Corticobasal degeneration

KW - Deep brain stimulation

KW - Diphasic dyskinesia

KW - Levodopa-induced-dyskinesia

KW - Multiple system atrophy

KW - Parkinson's disease

KW - Pathophysiology

KW - Progressive supranuclear palsy

UR - http://www.scopus.com/inward/record.url?scp=84886011938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886011938&partnerID=8YFLogxK

U2 - 10.1002/9781444346183.ch19

DO - 10.1002/9781444346183.ch19

M3 - Chapter

AN - SCOPUS:84886011938

SN - 1444333526

SN - 9781444333527

SP - 297

EP - 310

BT - Hyperkinetic Movement Disorders: Differential Diagnosis and Treatment

PB - Wiley-Blackwell

ER -